Français Geneva and Lausanne, Switzerland, 14 January 2025 – The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have … GARDP backs Debiopharm’s Swiss-developed compound to treat drug-resistant gonorrhoea infections
Seoul, 18 October 2024 – The Republic of Korea’s National Institute of Infectious Diseases (NIID) and the Global Antibiotic Research & Development Partnership (GARDP) have … The Republic of Korea’s National Institute of Infectious Diseases and GARDP team up to advance innovative clinical research on drug resistance
Geneva and Bangalore, 11 June 2024 – The Global Antibiotic Research & Development Partnership (GARDP) and Bugworks Research Inc. (Bugworks) today announced a collaboration agreement to co-develop … Novel broad-spectrum antibiotic compound prioritized for development in fight against AMR
Geneva, 29 May 2024 – The Global Antibiotic Research & Development Partnership (GARDP) and the Stop TB Partnership’s Global Drug Facility (GDF), hosted by UNOPS, … New partnership to improve access to new antibiotics in low- and middle-income countries to boost efforts to combat TB and AMR
Geneva, 21 February 2024 – The Global Antibiotic Research & Development Partnership (GARDP) announced today an additional investment of £2.5 million from the UK Government. The … UK Government pledges £2.5 million towards new antibiotic treatments
Geneva, Switzerland, 20 November 2023 – In a boost to efforts to counter antibiotic resistance, the Research Investment for Global Health Technology (RIGHT) Foundation has … The RIGHT Foundation invests in new treatments for neonatal sepsis
A phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current … Positive results announced in largest pivotal phase 3 trial of a first-in-class oral antibiotic to treat uncomplicated gonorrhoea
Geneva, 19 October 2023—The Government of Japan has granted additional funding to the Global Antibiotic Research & Development Partnership (GARDP) to support its vital work … Japan government funding supports GARDP’s efforts to counter antibiotic resistance
Osaka (Japan), Chennai (India), Geneva (Switzerland), Boston (USA), 12 September 2023—A new agreement is poised to accelerate antibiotic access for tens of thousands of patients … Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections
Geneva and Bangalore, 27 July 2023 – The Global Antibiotic Research & Development Partnership (GARDP) is joining forces with Bugworks Research Inc. (Bugworks), an innovative clinical-stage … GARDP and Bugworks join forces to accelerate development of a novel antibiotic to treat serious bacterial infections